Similar Items: Determination of the mechanism of synergy of SQ109 with rifampicin and isoniazid in Mycobacterium smegmatis
- The prevalence of isoniazid and rifampicin resistance of Mycobacterium tuberculosis
- Repositioning the antitubercular candidate SQ109 as potent antimalarial with polypharmacology
- Regulatory responses to rifampicin exposure in Mycobacterium tuberculosis
- Gene expression changes in macrophages infected with pathogenic M. tuberculosis and non-pathogenic M. smegmatis and M. bovis BCG
- Development of a drug discovery protocol through the expression of key mycothiol biosynthetic enzymes for Mycobacterium tuberculosis
- Deciphering the mechanisms of Isoniazid reisistance to mycobacterium tuberculosis
Author: Williams, Monique Joy
- Functional characterisation of a SufT homologue in mycobacterium smegmatis
- The identification of novel proteins involved in iron-sulphur cluster biogenesis in mycobacteria
- Investigating the role of a novel protein in iron–sulphur cluster biogenesis in mycobacteria
- Regulation of iron-sulphur cluster biogenesis in Mycobacterium tuberculosis
- Investigation of the expression and immunogenicity of Mycobacterium tuberculosis Rv1460
- Determination of the mechanism of synergy of SQ109 with rifampicin and isoniazid in Mycobacterium smegmatis